TDRKH [PCRP-TDRKH-1H2]

Clear

Summary

Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules.

Product Properties & Targets

Host
Species Reactivity
Isotype
Cellular Localization
Cytoplasm, Mitochondrion
Light Chain
Gene Name
Positive Control
HeLa or MCF7 cells. Human testis or brain.
Immunogen
Recombinant full-length human TDRKH protein
Alternate Names
Tudor and KH domain-containing protein, Tudor domain-containing protein 2, 2700091C21Rik; Putative RNA binding protein; RGD1311196; RP11-98D18.8; TDRD2; TDRD7; Tdrkh; Tudor and KH domain containing; Tudor and KH domain-containing protein; tudor domain containing 2

Database Links

Entrez Gene ID
Unigene
SwissProt

Additional Information

Clone
PCRP-TDRKH-1H2
Human Gene Symbol
TDRKH
Chromosome Location
1q21.3
Mol. Weight of Antigen
62.05kDa

Functions

  • Participates in the primary piRNA biogenesis pathway and is required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. The piRNA metabolic process mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Required for the final steps of primary piRNA biogenesis by participating in the processing of 31-37 nt intermediates into mature piRNAs. May act in pi-bodies and piP-bodies by transferring piRNA precursors or intermediates to or between these granules.

Known Applications & Suggested Dilutions

  • Immunoprecipitation (1-2ug per 100-500ug of total protein)
  • Flow Cytometry (1-2ug/million cells)
  • ,Immunofluorescence (1-2ug/ml)
  • Western Blot (1-2ug/ml)
  • ,Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95 &degC followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

Key References

  • A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors. Blackshaw S, et al. Nature methods 15.5 (2018 May): 330-338.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.

Reviews

There are no reviews yet.

Be the first to review “TDRKH”

Your email address will not be published. Required fields are marked *

Recombinant mouse monoclonal antibodies and recombinant rabbit monoclonals to support your research

Shop Primary Antibodies